Delivery Order SPE2DB24D2217-SPE2DB26FJVQC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,486.78 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit-dose packaging (100 count). This is a firm fixed price, non-set-aside delivery order with a completion date of September 2, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $12,037.36 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit dose packaging (100 count). This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of May 22, 2025. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,516.44 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lansoprazole DR 15 mg Orally Disintegrating Tablets in unit dose packaging (100 count). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without any set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $4,728.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lansoprazole DR 15 mg ODT UD 100s, a generic proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related conditions. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,769 units of Lansoprazole DR 30 mg ODT (Oral Disintegrating Tablet) for the Defense Logistics Agency (DLA). The firm-fixed price contract has a ceiling value of $42,232.08 and an ultimate completion date of September 12, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,397.52 contract is a Firm Fixed Price Delivery Order for the provision of 4,559,437,942 units of Lansoprazole ODT 15 mg Tablet UD 100s. The contract has an ultimate completion date of December 22, 2022 and was awarded on December 21, 2022. This delivery order is placed against AmerisourceBergen's $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $9,002.17 firm fixed-price contract is for the supply of 4,565,841,173 units of the prescription medication Lansoprazole DR 15 mg Oral Disintegrating Tablets. The ultimate completion date for this order is September 18, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,108.32 contract is for the delivery of 150 milliliters of the medication Lansoprazole 3 milligrams per milliliter. The contract has a completion date of March 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $22,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for 100 capsules of the pharmaceutical product lansoprazole DR 30 mg to be delivered to a location in Conshohocken, Pennsylvania by August 8, 2023. The Defense Logistics Agency will provide funding for this delivery of pharmaceutical supplies in support of its logistics and procurement...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,328.72 firm fixed-price delivery order is for the supply of lansoprazole delayed-release orally disintegrating tablets to support military treatment programs and facilities. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, through which the company...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB26FJVQCDelivery Order
The Defense Logistics Agency awarded a $3,105.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit dose packaging (100 count). This is a non-set-aside award with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs. Lansoprazole, a proton pump inhibitor commonly used for gastric acid management, falls within the company's extensive portfolio of generic and brand-name pharmaceutical products distributed to the Defense Health Agency and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 10/20/25 |